← Back to Analyst Consensus 
BCRX Buy
BIOCRYST PHARMACEUTICALS INC
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Sep 10, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Sep 8, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 30, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| May 7, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| May 7, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jan 30, 2026 | RBC Capital | maintain | Outperform → Outperform | $13 | 55% |
| Dec 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $32 | 44% |
| Nov 5, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $25 | 46% |
| Nov 4, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $9 | 53% |
| Nov 4, 2025 | Needham | maintain | Buy → Buy | $18 | 50% |
| Oct 15, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $26 | 50% |
| Oct 15, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $27 | 53% |
| Oct 15, 2025 | Needham | maintain | Buy → Buy | $20 | 50% |
| Aug 4, 2025 | Needham | maintain | Buy → Buy | $17 | 50% |
| Jul 1, 2025 | B of A Securities | maintain | Buy → Buy | $15 | 53% |
| Jun 30, 2025 | RBC Capital | reiterate | Outperform → Outperform | $13 | 55% |
| Jun 30, 2025 | Wedbush | maintain | Outperform → Outperform | $18 | 58% |
| Jun 27, 2025 | Needham | reiterate | Buy → Buy | $17 | 50% |
| Jun 25, 2025 | Needham | reiterate | Buy → Buy | $17 | 50% |
| May 7, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $11 | 53% |
| May 6, 2025 | RBC Capital | reiterate | Outperform → Outperform | $13 | 55% |
| May 6, 2025 | JP Morgan | maintain | Overweight → Overweight | $13 | 55% |
| May 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 6, 2025 | Needham | maintain | Buy → Buy | $17 | 50% |
| Apr 29, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $20 | 50% |
| Apr 11, 2025 | RBC Capital | reiterate | Outperform → Outperform | $11 | 55% |
| Apr 10, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Mar 3, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $18 | 49% |
| Feb 25, 2025 | RBC Capital | reiterate | Outperform → Outperform | $11 | 55% |
| Feb 25, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $18 | 49% |
| Feb 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Jan 31, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $18 | 53% |
| Jan 13, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $12 | 58% |
| Jan 13, 2025 | Needham | maintain | Buy → Buy | $15 | 50% |
| Dec 17, 2024 | Needham | maintain | Buy → Buy | $15 | 50% |
| Nov 5, 2024 | RBC Capital | reiterate | Outperform → Outperform | $10 | 55% |
| Nov 5, 2024 | Needham | reiterate | Buy → Buy | $14 | 50% |
| Nov 5, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $8 | 53% |
| Aug 6, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $16 | 53% |
| Aug 6, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $7 | 53% |
| Aug 6, 2024 | RBC Capital | reiterate | Outperform → Outperform | $10 | 55% |
| Aug 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 7, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $15 | 53% |
| May 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
Price Target Trend
Jun 2, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days